Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Moyé

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Controlled Clinical Trials|February 23, 1999
End-point interpretation in clinical trials: the case for disciplineL A Moyé
Controlled Clinical Trials|December 1, 1991
Central laboratory sampling plans and quality control in clinical trialsL A Moyé
Statistics in Medicine|March 29, 2000
Alpha calculus in clinical trials: considerations and commentary for the new millenniumL A Moyé
Annals of Epidemiology|August 26, 1998
P-value interpretation and alpha allocation in clinical trialsL A Moyé
Circulation|June 27, 2001
Random researchL A Moyé
American Clinical Laboratory|August 16, 2001
The perils of nonprospectively planned research. Part 1: drawing conclulsions from sample-based researchL A Moyé
American Clinical Laboratory|June 21, 2001
The perils of nonprospectively planned research. Part 2: Guidelines for reviewing the results of sample-based researchL A Moyé
Statistics in Medicine|November 14, 1997
Sizing clinical trials with variable endpoint event ratesL A Moyé
Controlled Clinical Trials|December 12, 2001
Trials within trials: confirmatory subgroup analyses in controlled clinical experimentsL A Moyé, A Deswal
The New England Journal of Medicine|October 24, 1996
Carvedilol in patients with chronic heart failureL A Moyé, D Abernethy
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Controlled Clinical Trials|February 23, 1999
End-point interpretation in clinical trials: the case for disciplineL A Moyé
Controlled Clinical Trials|December 1, 1991
Central laboratory sampling plans and quality control in clinical trialsL A Moyé
Statistics in Medicine|March 29, 2000
Alpha calculus in clinical trials: considerations and commentary for the new millenniumL A Moyé
Annals of Epidemiology|August 26, 1998
P-value interpretation and alpha allocation in clinical trialsL A Moyé
Circulation|June 27, 2001
Random researchL A Moyé
American Clinical Laboratory|August 16, 2001
The perils of nonprospectively planned research. Part 1: drawing conclulsions from sample-based researchL A Moyé
American Clinical Laboratory|June 21, 2001
The perils of nonprospectively planned research. Part 2: Guidelines for reviewing the results of sample-based researchL A Moyé
Statistics in Medicine|November 14, 1997
Sizing clinical trials with variable endpoint event ratesL A Moyé
Controlled Clinical Trials|December 12, 2001
Trials within trials: confirmatory subgroup analyses in controlled clinical experimentsL A Moyé, A Deswal
The New England Journal of Medicine|October 24, 1996
Carvedilol in patients with chronic heart failureL A Moyé, D Abernethy
Pageof 6